Skip to content
10-K

Annual Report

Humanigen, Inc.

0001214659-23-004512

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2022 · Dec 31, 2022 89.24M sh
Shares Diluted FY 2022 · Dec 31, 2021 58.53M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$76.7M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$184.05M
Cash And Equivalents FY 2022 · Dec 31, 2022 $10.16M
Cash And Equivalents FY 2022 · Dec 31, 2021 $70.02M
Stockholders Equity FY 2022 · Dec 31, 2022 −$46.77M
Stockholders Equity FY 2022 · Dec 31, 2021 −$23.69M
Stockholders Equity FY 2022 · Dec 31, 2020 $45.55M
Current Liabilities FY 2022 · Dec 31, 2022 $56.19M
Current Liabilities FY 2022 · Dec 31, 2021 $68.73M
Total Liabilities FY 2022 · Dec 31, 2022 $57.96M
Total Liabilities FY 2022 · Dec 31, 2021 $94.75M
Current Assets FY 2022 · Dec 31, 2022 $11.11M
Current Assets FY 2022 · Dec 31, 2021 $70.97M
Total Assets FY 2022 · Dec 31, 2022 $11.2M
Total Assets FY 2022 · Dec 31, 2021 $71.06M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.79
Eps Diluted FY 2022 · Dec 31, 2021 −$4.04
Eps Basic FY 2022 · Dec 31, 2022 −$0.79
Eps Basic FY 2022 · Dec 31, 2021 −$4.04
Sga Expense FY 2022 · Dec 31, 2022 $15.61M
Sga Expense FY 2022 · Dec 31, 2021 $23.25M
Rd Expense FY 2022 · Dec 31, 2022 $55.21M
Rd Expense FY 2022 · Dec 31, 2021 $213.12M
Net Income FY 2022 · Dec 31, 2022 −$70.73M
Net Income FY 2022 · Dec 31, 2021 −$236.65M
Operating Income FY 2022 · Dec 31, 2022 −$68.3M
Operating Income FY 2022 · Dec 31, 2021 −$232.77M
Revenue FY 2022 · Dec 31, 2022 $2.51M
Revenue FY 2022 · Dec 31, 2021 $3.6M
Stock Issued FY 2022 · Dec 31, 2021 6.41M sh
Long Term Debt FY 2022 · Dec 31, 2021 $25.01M